Evidence map›Paper›PMID 30788459›Full record

ArticleJournal of pancreatic cancer2018

Treatment with Lanreotide Depot Following Octreotide Long-Acting Release Among Patients with Gastroenteropancreatic Neuroendocrine Tumors.

Muhammad Wasif Saif, Julie Fu, Melissa H Smith, Barbara Weinstein, Valerie Relias, Kevin P Daly

Open access · goldAbstract read
In one paragraph

Article in Journal of pancreatic cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Medical Management of Gastroenteropancreatic Neuroendocrine Tumors.Surgical oncology clinics of North America · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Muhammad Wasif SaifDepartment of Medical Oncology, Tufts Cancer Center-Tufts Medical Center, Boston, Massachusetts.
Julie FuDepartment of Medical Oncology, Tufts Cancer Center-Tufts Medical Center, Boston, Massachusetts.
Melissa H SmithDepartment of Medical Oncology, Tufts Cancer Center-Tufts Medical Center, Boston, Massachusetts.
Barbara WeinsteinDepartment of Pathology, Tufts Cancer Center-Tufts Medical Center, Boston, Massachusetts.
Valerie ReliasDepartment of Medical Oncology, Tufts Cancer Center-Tufts Medical Center, Boston, Massachusetts.
Kevin P DalyDepartment of Invasive Radiology, Tufts Cancer Center-Tufts Medical Center, Boston, Massachusetts.
Tufts Medical Center · US

Funding

Tufts Clinical and Translational Research InstituteUL1TR001064 · NCATS · TUFTS UNIVERSITY BOSTON · PI SELKER, HARRY P. · 2013 to 2017
$26.4M
NCATS NIH HHS UL1 TR001064
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chromograningastroenteropancreatic neuroendocrine tumorslanreotide depotoctreotide long-acting release

Identifiers

PMID30788459
PMCPMC6371583
OpenAlexW2898371239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.